Form 8.3 - HORIZON THERAPEUTICS PLC

Barclays PLC
09 October 2023
 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2007 (AS AMENDED)

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES

REPRESENTING 1% OR MORE

1.

KEY INFORMATION

Name of person dealing (Note 1)

Barclays PLC.

Company dealt in

HORIZON THERAPEUTICS PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

$0.001 ordinary shares

Date of dealing

06 Oct 2023

2.

INTERESTS AND SHORT POSITIONS

(a)

Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:

$0.001 ordinary shares


Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities 

126,460

0.06%

58,082

0.03%

(2)

Derivatives (other than options):

0

0.00%

0

0.00%

(3)

Options and agreements to purchase/sell:

0

0.00%

0

0.00%

TOTAL:

126,460

0.06%

58,082

0.03%

(b)

Interests and short positions in relevant securities of the company, other than the class dealt in

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

(3)

Options and agreements to purchase/sell:

 

 

 

 

TOTAL:

 

 

 

 

3.

DEALINGS (Note 4)

(a)

Purchase and sales

 






Class of relevant Security

Purchase/sale

Number of securities

Price per unit

 

 

 

 

 
















(b)

Derivatives transactions (other than option transactions)

Product Name

Nature of transaction

Number of relevant securities

Price per unit

 

 

 

 

 
















(c)

Options transactions in respect of existing securities

(i)

Writing, selling, purchasing or varying

Class  of  relevant  security

Product  description

Writing,  purchasing,  selling,  varying etc

Number  of  securities  to which  option  relates

Exercise  price per unit

Type

Expiry  date

Option  money  paid/  received  per unit

 

 

 

 

 

 

 

 

 
















(ii)

Exercising

 






Product name

Number of

 securities

Exercise price

 per unit

 

 

 

 
















(d)

Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

Details

Price per unit

 (if applicable)

 

 

 

4.

OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing

 and any other person relating to the voting rights of any relevant securities under any option

 referred to on this form or relating to the voting rights or future acquisition or disposal of any

 relevant securities to which any derivative referred to on this form is referenced. If none, this

 should be stated.

NONE

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

09 Oct 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Barclays (BARC)
UK 100

Latest directors dealings